Primer: Acotec Scientific Holdings (6669 HK) - Oct 2025
Acotec Scientific is a leading domestic player in China's drug-coated balloon (DCB) market, poised to benefit from the growing prevalence of...
181 Views
Zylox Tonbridge Medical (2190 HK): No More Interventions Needed, Blockages Cleared for Growth
​Zylox-Tonbridge Medical carried forward 2024 momentum, moving into 1H25. New launches and strong market sales capabilities will help drive the...
349 Views
Zylox-Tonbridge Medical Technology (2190.HK) - A Good Alpha-Generating Opportunity for Investors
​Zylox's strong fundamentals and growth potential have not been fully reflected in current valuation due to market conditions, making it a...
512 Views
Pre-IPO Zylox-Tonbridge Medical Technology - Promising Market with Challenges
This insights analyzed Zylox-Tonbridge Medical Technology in terms of the market potential, industry characteristics, business analysis, financial...
522 Views
APAC Healthcare Weekly (December 7) – Simcere, Kelun Bio, Samsung Biologics, Daiichi Sankyo, Biocon
Simcere stuck license pact with Vigonvita. Kelun Bio inked partnership with Crescent Biopharma. Samsung Biologics is acquiring land for third...
475 Views